Clinical Trial Update: The Impact of an Antibiotic (Cefazolin) Before Surgery on the Microbiome in Patients With Stage I-II Melanoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating whether preoperative Cefazolin affects the gut microbiome in patients with stage I–II cutaneous melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma

Drugs mentioned

• CEFAZOLIN (cefazolin sodium)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8 | Phase 1 | Status: ACTIVE_NOT_RECRUITING